Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters
Database
Type of study
Language
Document Type
Year range
1.
Vaccines and Atrial Fibrillation: A Real-World Pharmacovigilance Study Based on Vaccine Adverse Event Reporting System.
Al-Yafeai, Zaki; Ghoweba, Mohamed; Aziz, David; Ananthaneni, Anil; Sabayon, Muhie Dean.
Am J Ther ; 30(2): 151-153, 2023.
Article in English | MEDLINE | ID: covidwho-2248730

Subject(s)
Atrial Fibrillation , Vaccines , Humans , Atrial Fibrillation/drug therapy , Atrial Fibrillation/chemically induced , Pharmacovigilance , Vaccines/adverse effects , Adverse Drug Reaction Reporting Systems
2.
A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination.
Al-Yafeai, Zaki; Horn, Benjamin Joesph M; Terraccaine, William; Jose, Alvin; Krishnan, Prathik.
Cureus ; 14(3): e23162, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1771731

ABSTRACT

In this report, we examine the case of a patient who developed antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after receiving the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. This is a case of a 62-year-old female who received the first dose of COVID-19 vaccine in July 2021 before presenting a few weeks later with migrating polyarthralgia and hemoptysis. Autoimmune workup was positive for ANCA against proteinase 3 (PR3).

SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL